Impact of switching between reference biologics and biosimilars of tumour necrosis factor inhibitors for rheumatoid arthritis: a systematic review and network meta-analysis

What is the impact of switching between biologics and biosimilars of adalimumab, etanercept, and infliximab on efficacy and safety for rheumatoid arthritis? A systematic review and network meta-analysis were performed to compare switching and non-switching groups of treatments. Pooled Risk Relative...

Descripción completa

Detalles Bibliográficos
Autores principales: de Oliveira Ascef, Bruna, Almeida, Matheus Oliveira, de Medeiros-Ribeiro, Ana Cristina, de Oliveira Andrade, Danieli Castro, de Oliveira Junior, Haliton Alves, de Soárez, Patrícia Coelho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444768/
https://www.ncbi.nlm.nih.gov/pubmed/37607959
http://dx.doi.org/10.1038/s41598-023-40222-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444768/
https://www.ncbi.nlm.nih.gov/pubmed/37607959
http://dx.doi.org/10.1038/s41598-023-40222-5

Ejemplares similares